ATE402696T1 - Heterozyklische amidderivate, die glycogen phosphorylase inhibierende aktivität besitzen - Google Patents
Heterozyklische amidderivate, die glycogen phosphorylase inhibierende aktivität besitzenInfo
- Publication number
- ATE402696T1 ATE402696T1 AT04743648T AT04743648T ATE402696T1 AT E402696 T1 ATE402696 T1 AT E402696T1 AT 04743648 T AT04743648 T AT 04743648T AT 04743648 T AT04743648 T AT 04743648T AT E402696 T1 ATE402696 T1 AT E402696T1
- Authority
- AT
- Austria
- Prior art keywords
- sup
- alkyl
- glycogen phosphorylase
- sub
- inhibiting activity
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Heart & Thoracic Surgery (AREA)
- Child & Adolescent Psychology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pyridine Compounds (AREA)
- Indole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0318463.7A GB0318463D0 (en) | 2003-08-07 | 2003-08-07 | Chemical compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE402696T1 true ATE402696T1 (de) | 2008-08-15 |
Family
ID=27839758
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT04743648T ATE402696T1 (de) | 2003-08-07 | 2004-08-04 | Heterozyklische amidderivate, die glycogen phosphorylase inhibierende aktivität besitzen |
Country Status (9)
Country | Link |
---|---|
US (1) | US20080064691A1 (de) |
EP (1) | EP1658069B1 (de) |
JP (1) | JP2007501779A (de) |
AT (1) | ATE402696T1 (de) |
DE (1) | DE602004015474D1 (de) |
ES (1) | ES2309537T3 (de) |
GB (1) | GB0318463D0 (de) |
HK (1) | HK1090288A1 (de) |
WO (1) | WO2005013981A1 (de) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0205170D0 (en) | 2002-03-06 | 2002-04-17 | Astrazeneca Ab | Chemical compounds |
GB0205162D0 (en) | 2002-03-06 | 2002-04-17 | Astrazeneca Ab | Chemical compounds |
GB0205176D0 (en) | 2002-03-06 | 2002-04-17 | Astrazeneca Ab | Chemical compounds |
GB0205175D0 (en) | 2002-03-06 | 2002-04-17 | Astrazeneca Ab | Chemical compounds |
GB0205165D0 (en) | 2002-03-06 | 2002-04-17 | Astrazeneca Ab | Chemical compounds |
GB0222909D0 (en) | 2002-10-03 | 2002-11-13 | Astrazeneca Ab | Novel process and intermediates |
GB0222912D0 (en) | 2002-10-03 | 2002-11-13 | Astrazeneca Ab | Novel process and intermediates |
BRPI0606838A2 (pt) * | 2005-02-05 | 2010-02-09 | Astrazeneca Ab | composto ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, uso de um composto ou um sal farmaceuticamente aceitável do mesmo, e, processo para preparação de um composto ou um sal farmaceuticamente aceitável do mesmo |
WO2007081542A2 (en) | 2006-01-06 | 2007-07-19 | Sepracor Inc. | Tetralone-based monoamine reuptake inhibitors |
EP1976513B1 (de) | 2006-01-06 | 2016-08-24 | Sunovion Pharmaceuticals Inc. | Cycloalkylamine als monoamin-wiederaufnahmehemmer |
EP2816024B8 (de) | 2006-03-31 | 2018-04-04 | Sunovion Pharmaceuticals Inc. | Chirale Amine |
PE20080251A1 (es) | 2006-05-04 | 2008-04-25 | Boehringer Ingelheim Int | Usos de inhibidores de dpp iv |
US7884124B2 (en) | 2006-06-30 | 2011-02-08 | Sepracor Inc. | Fluoro-substituted inhibitors of D-amino acid oxidase |
US7902252B2 (en) | 2007-01-18 | 2011-03-08 | Sepracor, Inc. | Inhibitors of D-amino acid oxidase |
WO2008151156A1 (en) | 2007-05-31 | 2008-12-11 | Sepracor Inc. | Phenyl substituted cycloalkylamines as monoamine reuptake inhibitors |
CN102264228A (zh) | 2008-10-22 | 2011-11-30 | 默沙东公司 | 用于抗糖尿病药的新的环状苯并咪唑衍生物 |
CN102271509A (zh) | 2008-10-31 | 2011-12-07 | 默沙东公司 | 用于抗糖尿病药的新型环苯并咪唑衍生物 |
CA2786314A1 (en) | 2010-02-25 | 2011-09-01 | Merck Sharp & Dohme Corp. | Novel cyclic benzimidazole derivatives useful anti-diabetic agents |
CN103476258B (zh) | 2011-02-25 | 2017-04-26 | 默沙东公司 | 用作抗糖尿病药剂的新的环状氮杂苯并咪唑衍生物 |
JP2015525782A (ja) | 2012-08-02 | 2015-09-07 | メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. | 抗糖尿病性三環式化合物 |
MX2015010935A (es) | 2013-02-22 | 2015-10-29 | Merck Sharp & Dohme | Compuestos biciclicos antidiabeticos. |
US9650375B2 (en) | 2013-03-14 | 2017-05-16 | Merck Sharp & Dohme Corp. | Indole derivatives useful as anti-diabetic agents |
WO2015051496A1 (en) | 2013-10-08 | 2015-04-16 | Merck Sharp & Dohme Corp. | Antidiabetic tricyclic compounds |
US11072602B2 (en) | 2016-12-06 | 2021-07-27 | Merck Sharp & Dohme Corp. | Antidiabetic heterocyclic compounds |
US10968232B2 (en) | 2016-12-20 | 2021-04-06 | Merck Sharp & Dohme Corp. | Antidiabetic spirochroman compounds |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3706810A (en) * | 1970-09-15 | 1972-12-19 | American Cyanamid Co | N-morpholinoalkyl-thieno(3,2-b)pyrrole-5-carboxamides |
US4692522A (en) * | 1985-04-01 | 1987-09-08 | Merck & Co., Inc. | Benzofused lactams useful as cholecystokinin antagonists |
US4668769A (en) * | 1985-08-02 | 1987-05-26 | Hoover Dennis J | Oxa- and azahomocyclostatine polypeptides |
US4599198A (en) * | 1985-08-02 | 1986-07-08 | Pfizer Inc. | Intermediates in polypeptide synthesis |
US4720503A (en) * | 1985-08-02 | 1988-01-19 | Merck & Co., Inc. | N-substituted fused-heterocyclic carboxamide derivatives as dual cyclooxygenase and lipoxygenase inhibitors |
FR2601368B1 (fr) * | 1986-07-08 | 1989-04-07 | Synthelabo | Derives de nitrofuranne, leur preparation et leur application en therapeutique. |
DE3629545A1 (de) * | 1986-08-30 | 1988-03-10 | Bayer Ag | Dihydropyridinverbindungen, verfahren zu ihrer herstellung und ihre verwendung |
US4751231A (en) * | 1987-09-16 | 1988-06-14 | Merck & Co., Inc. | Substituted thieno[2,3-b]pyrrole-5-sulfonamides as antiglaucoma agents |
US5863903A (en) * | 1994-03-09 | 1999-01-26 | Novo Nordisk A/S | Use of hydroxy alkyl piperidine and pyrrolidine compounds to treat diabetes |
US5998463A (en) * | 1998-02-27 | 1999-12-07 | Pfizer Inc | Glycogen phosphorylase inhibitors |
EP1136071A3 (de) * | 2000-03-22 | 2003-03-26 | Pfizer Products Inc. | Verwendung von Glykogen-Phosphorylase-Hemmern |
GB0021831D0 (en) * | 2000-09-06 | 2000-10-18 | Astrazeneca Ab | Chemical compounds |
GB0205170D0 (en) * | 2002-03-06 | 2002-04-17 | Astrazeneca Ab | Chemical compounds |
US7057046B2 (en) * | 2002-05-20 | 2006-06-06 | Bristol-Myers Squibb Company | Lactam glycogen phosphorylase inhibitors and method of use |
US20040082641A1 (en) * | 2002-10-28 | 2004-04-29 | Rytved Klaus Asger | Use of glycogen phosphorylase inhibitors for treatment of cardiovascular diseases |
US7098235B2 (en) * | 2002-11-14 | 2006-08-29 | Bristol-Myers Squibb Co. | Triglyceride and triglyceride-like prodrugs of glycogen phosphorylase inhibiting compounds |
MXPA05011702A (es) * | 2003-04-30 | 2006-01-23 | Pfizer Prod Inc | Agentes antidiabeticos. |
-
2003
- 2003-08-07 GB GBGB0318463.7A patent/GB0318463D0/en not_active Ceased
-
2004
- 2004-08-04 EP EP04743648A patent/EP1658069B1/de not_active Not-in-force
- 2004-08-04 JP JP2006522397A patent/JP2007501779A/ja not_active Withdrawn
- 2004-08-04 DE DE602004015474T patent/DE602004015474D1/de not_active Expired - Fee Related
- 2004-08-04 US US10/566,063 patent/US20080064691A1/en not_active Abandoned
- 2004-08-04 AT AT04743648T patent/ATE402696T1/de not_active IP Right Cessation
- 2004-08-04 WO PCT/GB2004/003345 patent/WO2005013981A1/en active IP Right Grant
- 2004-08-04 ES ES04743648T patent/ES2309537T3/es active Active
-
2006
- 2006-09-29 HK HK06110903A patent/HK1090288A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
ES2309537T3 (es) | 2008-12-16 |
DE602004015474D1 (de) | 2008-09-11 |
WO2005013981A1 (en) | 2005-02-17 |
US20080064691A1 (en) | 2008-03-13 |
EP1658069A1 (de) | 2006-05-24 |
EP1658069B1 (de) | 2008-07-30 |
GB0318463D0 (en) | 2003-09-10 |
HK1090288A1 (en) | 2006-12-22 |
JP2007501779A (ja) | 2007-02-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1090288A1 (en) | Heterocyclic amide derivatives which possess glycogen phosphorylase inhibitory activity | |
ES2308441T3 (es) | Compuestos de imidazol para el tratamiento de trastornos neurodegenerativos. | |
HK1089965A1 (en) | Indolamide derivatives which possess glycogen phosphorylase inhibitory activity | |
PT1024138E (pt) | Derivados de pirazole | |
BR0308146A (pt) | Composto, composição farmacêutica, uso de um composto, e, processo para a preparação de um composto | |
EP3088397A1 (de) | Verbindungen, die den g2-checkpoint des zellzyklus stilllegen und dadurch eine antikrebswirkung aufweisen | |
TW200732329A (en) | Aryl-isoxazolo-4-yl-oxadiazole derivatives | |
CA2526026C (en) | Furazanobenzimidazoles | |
CA2042922A1 (en) | Anti-tumour compounds | |
BR0308145A (pt) | Composto, composição farmacêutica, uso de um composto, e, processo para a preparação de um composto | |
CN100390156C (zh) | 新抗菌化合物、其制备方法和含有它们的药物组合物 | |
ES2308442T3 (es) | Compuestos de pirazolamina para el tratamiento de trastornos neurodegenerativos. | |
JP2007505888A (ja) | オキシトシン拮抗薬としての置換トリアゾール誘導体 | |
AU680496B2 (en) | Novel bisoxadiazolidine derivative | |
US5760063A (en) | Arylhydrazone derivatives useful as antibacterial agents | |
Yonetoku et al. | Novel potent and selective Ca2+ release-activated Ca2+ (CRAC) channel inhibitors. Part 3: Synthesis and CRAC channel inhibitory activity of 4′-[(trifluoromethyl) pyrazol-1-yl] carboxanilides | |
EP0737672B1 (de) | Verfahren zur Herstellung von Triazinderivate | |
BG107908A (bg) | Инхибитори на фарнезилтрансфераза | |
TW200510304A (en) | Chemical compounds | |
WO2003074485A3 (en) | Indole-amide derivatives and their use as glycogen phosphorylase inhibitors | |
JP6927959B2 (ja) | ベンジリデングアニジン誘導体と化学療法剤の併用による癌の治療方法 | |
PL171273B1 (pl) | Sposób wytwarzania nowych pochodnych tiadiazynonów PL | |
EP2188257A2 (de) | Sulfoximinderivate als faktor-xa-hemmer | |
US6166033A (en) | 2-carbonylthiazole derivatives and use of the same | |
EP3544685B1 (de) | Hetroarylaminverbindungen zur modulierung des hedgehog-signalwegs und herstellungsverfahren und verwendungen davon |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |